Skip to content
Screener

Roivant Sciences ROIV Business Segments — Income tax expense (benefit)

Similar metrics at other companies

Intuitive Machines, Inc. logo
LUNRReportable Segment — Income tax expense (benefit)
$2K
Tilly's logo
TLYSReportable Segment — Income tax expense (benefit)
$137K+199%
LPR
LPROReportable Segment — Income tax expense (benefit)
-$10K-118%
ADT logo
ADTReportable Segment — Income tax expense (benefit)
$58.11M+13.9%
Reddit logo
RDDTReportable Segment — Income tax expense (benefit)
$1.75M+202%
Castle Biosciences logo
CSTLReportable Segment — Income tax expense (benefit)
$109K+126%

Other financials

Income statement

See full
Revenue$1.4M-33.5%
Operating income-$366.0M-28.5%
Net income-$189.8M+15.0%
EPS (diluted)-$0.26+21.2%

Balance sheet

See full
Cash & equivalents$77.1M-18.7%
Total debt$107.2M+7.5%
Total equity$4.2B-2.6%
Total assets$5.3B+5.4%

Cash flow

See full
Operating cash flow-$270.5M-32.4%
CapEx$419.0K-89.6%
Free cash flow-$270.9M-30.0%

Valuation

See full
Market cap$25.37B+219%
Enterprise value$25.4B+219%
P/S3,368×+3,026×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp
FCF margin-10,901%-22,382pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0.0×
Current ratio16.7×-23.8×

Where this comes from

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The source filing: Roivant Sciences’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:28 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q2 2026
Accession
0001635088-26-000090
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025
Other general and administrative expenses34,70632,830
Gain on litigation settlement(392)
Change in fair value of investments(36,637)19,125
Change in fair value of liability instruments2,329
Interest income(36,922)(48,322)
Other expense, net2,13011,208
Income tax (benefit) expense(3,958)4,649
Net loss$(290,606)$(273,911)

Item 1. Financial Statements (Unaudited).

FAQ

What is Roivant Sciences's business segments — income tax expense (benefit)?
Roivant Sciences (ROIV) reported business segments — income tax expense (benefit) of -$3.96M in Q2 2026.
How has Roivant Sciences's business segments — income tax expense (benefit) changed year-over-year?
Roivant Sciences's business segments — income tax expense (benefit) decreased by 185.1% year-over-year, from $4.65M to -$3.96M.
What is the long-term trend for Roivant Sciences's business segments — income tax expense (benefit)?
Over 2 years (2023 to 2025), Roivant Sciences's business segments — income tax expense (benefit) has grown at a 149.0% compound annual growth rate (CAGR), from $21.5M to $133.33M.
What does business segments — income tax expense (benefit) mean?
This represents the portion of the total income tax expense or benefit specifically allocated to a distinct reportable business segment. It reflects the tax impact of the segment's operational performance, considering applicable jurisdictional tax rates and segment-specific tax adjustments. This metric is essential for evaluating the after-tax profitability contribution of individual business units.

Ask your AI about Roivant Sciences's business segments — income tax expense (benefit).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude